Listed

Outset Medical, Inc.

OMNasdaqCIK 1484612HealthcareFiscal year ends Dec 31

Reports and events: 103 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Outset Medical, Inc., Reports and events
FiledFormWhat it isAccession number
2024-01-0216:41 ET8-K2.03 New direct financial obligation0000950170-24-000306
2023-12-1116:00 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0000950170-23-069380
2023-11-0817:54 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-060476
2023-11-0716:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-060250
2023-10-1216:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-053108
2023-08-0318:02 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-037387
2023-08-0216:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-037134
2023-07-0717:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-183869
2023-06-0116:06 ET8-K5.07 Shareholder vote results0000950170-23-025692
2023-05-0418:09 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-017341
2023-05-0316:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-017186
2023-04-1316:06 ETDEF 14AProxy statement0000950170-23-012706
2023-02-1317:19 ET10-KAnnual reportPeriod 2022-12-310000950170-23-002648
2023-02-1316:15 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-23-002612
2023-01-0908:45 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-000462
2022-11-0917:55 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-023370
2022-11-0816:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-023229
2022-11-0408:45 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-022068
2022-08-0216:01 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-013857
2022-08-0110:09 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-013586
2022-06-1316:16 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-011557
2022-06-0116:53 ET8-K5.07 Shareholder vote results0000950170-22-011033
2022-05-0518:21 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-007473
2022-05-0416:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-007400
2022-04-2516:19 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-006095
2022-04-1416:06 ETDEF 14AProxy statementPeriod 2022-05-310001564590-22-014464
2022-02-2316:01 ET10-KAnnual reportPeriod 2021-12-310000950170-22-001769
2022-02-1616:36 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-001362
2021-11-0418:11 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-002879
2021-11-0316:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-002832
2021-08-0618:03 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-041765
2021-08-0516:16 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-041598
2021-07-0117:04 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-206486
2021-06-0416:00 ET8-K5.07 Shareholder vote results0001564590-21-031775
2021-05-2416:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-029529
2021-05-0618:14 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-024269
2021-05-0516:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-024014
2021-04-2116:05 ETDEF 14AProxy statementPeriod 2021-06-030001564590-21-019807
2021-04-1316:12 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-114695
2021-04-0616:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-107658
2021-04-0616:13 ETS-1Registration statement0001193125-21-107588
2021-03-2409:16 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-014981
2021-03-2216:01 ET10-KAnnual reportPeriod 2020-12-310001564590-21-014563
2021-03-0916:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-011742
2021-02-2216:00 ET8-K8.01 Other events0001564590-21-007155
2021-01-1216:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-001005
2020-11-3017:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-305714
2020-11-3017:01 ETS-1Registration statement0001193125-20-305704
2020-11-1208:01 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-053315
2020-11-1207:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-053300

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:29 ET. Listed shows no prices and gives no investment advice.